Ralph Dr. Kern is COO and Chief Medical Officer at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). They have made 1 open-market trade across 1 company since 2019, most recently 2022-03-06.
CIK 0001699684
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BCLI | 223,310 | $264K |
Shares reported on the most recent Form 4, priced at the 2022-03-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BCLI | BUY | 2019-12-24 | 2019-12-27 | $3.88 | $12K | +5.2% | +1.0% | +18.6% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.